An international randomised trial of low-dose aspirin to prevent recurrent venous thromboembolism (INSPIRE)

Funding Activity

Website
http://purl.org/au-research/grants/nhmrc/570967

Funding Status
Closed

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

Patients who develop venous blood clots or pulmonary embolism, without an underyling cause, are at very high risk of recurrence once anticoagulant treatment (warfarin) is discontinued. The international INSPIRE trial is assessing whether low-dose aspirin treatment (a simple and cheap alternative to warfarin) is effective and safe in preventing further blood clots. If proven effective, aspirin could potentially prevent thousands of patients worldwide from experiencing such events.

Funded Activity Details

Start Date: 01-01-2009

End Date: 01-01-2014

Funding Scheme: NHMRC Project Grants

Funding Amount: $1,989,986.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Nutrigenomics and personalised nutrition

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

Aspirin | Deep venous thrombosis | Prevention | Pulmonary embolism | Secondary prevention | Thromboembolic disease | Thrombosis

Related Links